What is Progyny's EBITDA?

Progyny (PGNY) reported EBITDA of $36.86M in Q1 2026.

How has Progyny's EBITDA changed year-over-year?

Progyny's EBITDA increased by 45.8% year-over-year, from $25.28M to $36.86M.

What is the long-term trend for Progyny's EBITDA?

Over 4 years (2021 to 2025), Progyny's EBITDA has grown at a 28.0% compound annual growth rate (CAGR), from $33.64M to $90.23M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Progyny PGNY EBITDA

EBITDA at other companies

Pediatrix Medical GroupMD

$47.78M+27.6%

OrganonOGN

$363M+40.2%

BillionToOne, Inc. BLLN

$19.57M+3,849%

CVS HealthCVS

——

UnitedHealth GroupUNH

——

Natera, Inc.NTRA

——

Other financials

Income statement

See full

Revenue$328.5M+1.4%

Gross profit$83.1M+9.6%

Operating income$35.4M+46.4%

Net income$24.2M+60.9%

EPS (diluted)$0.29+70.6%

Balance sheet

See full

Cash & equivalents$131.6M+20.5%

Total debt$27.3M-5.6%

Total equity$439.3M-6.0%

Total assets$698.3M-4.4%

Cash flow

See full

Operating cash flow$45.9M-7.7%

CapEx$6.3M+123%

Free cash flow$39.6M-15.7%

Valuation

See full

Market cap$2.09B-27.1%

Enterprise value$1.98B-29.6%

P/E30.8×-23.7×

P/S1.6×-0.7×

Profitability

See full

Gross margin24.1%+2.1pp

Operating margin7.5%+1.4pp

Net margin5.2%+0.9pp

FCF margin14.3%-1.9pp

Returns & leverage

See full

Return on equity14.9%+4.8pp

Debt / equity0.1×0.0×

Current ratio2.1×-0.3×

Where this comes from

Calculated from Progyny’s reported figures.

$35.4Mebit+

$1.5MDepreciation Depletion & Amortization

=$36.86M

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Progyny's EBITDA?: Progyny (PGNY) reported EBITDA of $36.86M in Q1 2026.
How has Progyny's EBITDA changed year-over-year?: Progyny's EBITDA increased by 45.8% year-over-year, from $25.28M to $36.86M.
What is the long-term trend for Progyny's EBITDA?: Over 4 years (2021 to 2025), Progyny's EBITDA has grown at a 28.0% compound annual growth rate (CAGR), from $33.64M to $90.23M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.